Cerebral metabolism in opiate-dependent subjects: Effects of methadone maintenance

Mount Sinai Journal of Medicine

Volumn 67, Issue 5-6, 2000, Pages 381-387

  Galynker, Igor I ^a,c   Watras Ganz, Sniezyna ^a   Miner, Christian ^a   Rosenthal, Richard N ^a   Des Jarlais, Don C ^a   Richman, Beverly L ^a   London, Edythe ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Cerebral metabolism; Methadone maintenance; Opiate dependency

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHADONE; OPIATE;

ADULT; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; METABOLIC RATE; METHADONE TREATMENT; NEUROBIOLOGY; OPIATE ADDICTION; POSITRON EMISSION TOMOGRAPHY;

ADULT; ANALGESICS, OPIOID; BRAIN; CASE-CONTROL STUDIES; FEMALE; GYRUS CINGULI; HUMANS; MALE; METHADONE; OPIOID-RELATED DISORDERS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033736335     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Kreek MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis 1996; 15:73-96.
2. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991.
3. Condelli WS, Dunteman GH. Exposure to methadone programs and heroin use. Am J Drug Alcohol Abuse 1993; 19:65-78.
4. Dole VP. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260:3025-3029.
5. Goldstein A. Heroin addiction: Neurobiology, pharmacology, and policy. J Psychoactive Drugs 1991; 23:122-123.
6. Ball JC, Lange WR, Meyers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988; 29:214-216.
7. Iguchi MY, Maxine SL. Predictors of opiate drug abuse during a 90-day methadone detoxification. Am J Drug Alcohol Abuse 1991; 17:279-294.
8. Latowsky M. Improving detoxification outcomes from methadone treatment: The interrelationship of affective states and protracted withdrawal. J Psychoactive Drugs 1996; 28:251-257.
9. Ward J, Mattick R, Hall W. Key issues in methadone maintenance treatment. National drug and alcohol research center. Kensington: New South Wales University Press, Ltd.; 1992.
10. Kell MJ. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: Generation of plasma response curves. J Addict Dis 1995; 14:85-108.
11. O'Brien CP. Recent developments in the pharmacotherapy of substance abuse. J Consult Clin Psychol 1996; 64:677-686.
12. Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53:401-407.
13. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus methadone in treatment of opioid-dependent cocaine users. Psychopharmacology 1994; 116:401-406.
14. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol 1996; 16:58-67.
15. London ED, Broussolle EPM, Links JM, et al. Morphine-induced metabolic changes in human brain: Studies with positron emission tomography and [F18]fluorodeoxyglucose. Arch Gen Psychiatry 1990; 47:73-81.
16. Walsh SI, Stapleton KI, Preston JT, et al. Acute effects of buprenorphine on cerebral glucose utilization in human substance abusers. Soc Neurosci Abstr 1992; 18:371.
17. van Dyck CH, Rosen MI, Thomas HM, et al. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Res 1994; 55:181-191.
18. Krystal JH, Woods SW, Kosten TR, et al. Opiate dependence and withdrawal: Preliminary assessment using single photon emission computerized tomography (SPECT). Am J Drug Alcohol Abuse 1995; 21:47-63.
19. Kupers RC, Konings H, Adriansen H, Gybels JM. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991; 47:5-12.
20. Adler LJ, Gyuali FE, Diehl DJ, et al. Regional brain activity changes associated with fentanyl analgesia. Anesth Analg 1997; 84:120-126.
21. Talbot JD, Marrett S, Evans AC, et al. Multiple representations of pain in human cerebral cortex. Science 1991; 251:1355-1356.
22. Derbyshire SWG, Jones AKP, Brown WD, et al. Cortical and subcortical responses to pain in male and female volunteers [letter]. J Cereb Blood Flow Metab 1993; 13:546.
23. Casey KL, Minoshima S, Berger, KL, et al. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol 1994; 71:802-807.
24. Coghill RC, Talbot JD, Evans AC, et al. Distributed processing of pain and vibration by the human brain. J Neurosci 1994; 14:4095-4106.
25. Hsieh J, Belfrage M, Stone-Elander S, et al. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995; 63:225-236.
26. Vogt BA, Derbyshire S, Jones AKP. Pain processing in four regions of human cingulate cortex localized with co-registered PET and MR imaging. Eur J Neurosci 1996; 8:1461-1473.
27. Kreek MJ. Opioid receptors: Some perspectives from the early studies of their roles in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 1996b; 21:14-88.
28. Spitzer RL, Williams JBW, Gibbon M, et al. Structured clinical interview for DSM-III-R: (SCID). Washington (DC): American Psychiatric Press; 1990.
29. Mejia AA, Nakamura T, Masatoshi I, et al. Estimation of absorbed doses in humans due to intravenous administration of [F18]fluorodeoxyglucose in PET studies. J Nucl Med 1991; 32:699-706.
30. Liang K-Y, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
31. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-130.
32. Jones AKP, Friston KJ, Qi LY, et al. Sites of action of morphine in the brain [letter]. Lancet 1991a; 33:825.
33. Holman BL, Carvalho PA, Mendelson J, et al. Brain perfusion is abnormal in cocaine-dependent polydrug users: A study using Technetium-99m-HMPAO and a SPECT. J Nucl Med 1991;32:1206-1210.
34. Stapleton JM, Morgan MJ, Phillips RL, et al. Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology 1995; 13:21-31.
35. Derbyshire SWG, Jones AKP, Devani P, et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psychiatry 1994; 57:1166-1172.
36. Roland PE. Cortical representation of pain. Trends Neurosci 1992; 15:3-5.
37. Kaiko RF, Wallenstein SL, Rogers AG, et al. Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med 1981; 304:1501-1505.
38. George MS, Ketter TA, Parekh PI, et al. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry 1996; 40:859-871.